FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/17/2022
Back to search
Official data from USPTO
HEMACORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
10/17/2022
Trademark type
Combined
Nice classes
5, 9, 10
Filing date
08/20/2020
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
RU
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized tree design made up of four red branches and two grey branches with red leaves which cross and interweave and form a rounded crown. Below the design is the term "HEMACORE" with "HEMA" in red and "CORE" in grey. All on a white background.
Holders and representatives
Holders
Limited Liability Company "Hematological Corporation"
Representatives
Marina Sigareva Volpe Koenig
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Blood plasmafor the diagnosis of hemostasis; albuminous preparations for medical purposesfor the diagnosis and treatment of hemostatic disorders; biological preparations for medical purposesfor the diagnosis and treatment of hemostatic disorders; diagnostic preparations for medical purposes; enzyme preparations for medical purposesfor the diagnosis and treatment of hemostatic disorders; chemical reagents for medical or veterinary purposesfor the diagnosis and treatment of hemostatic disorders; saltssodium saltscalcium saltsfor medical purposesfor the diagnosis and treatment of hemostatic disorders; enzymes for medical purposesfor the diagnosis and treatment of hemostatic disorders
Class 9
Testing apparatus not for medical purposesfor testing biological compounds; monitoring apparatusother than for medical purposesfor monitoring of spatiotemporal dynamics of biochemical reactions; apparatus and instruments for physicsthermostatspressure indicatorstemperature indicators; chemistry apparatus and instrumentsscattering metersspectrophotometers; measuring apparatusfor measuring of spatiotemporal dynamics of biochemical reactions; computer programsrecorded for scientificbiological and medical purposes for performing tests and processing data; computer softwarerecordedfor scientificbiological and medical purposes for performing tests and processing data
Class 10
Testing apparatus for medical purposesfor the diagnosis of hemostasis; blood testing apparatusfor the diagnosis of hemostasis; diagnostic apparatus for medical purposesfor the diagnosis of hemostasis; medical apparatus and instrumentsfor the diagnosis and treatment of hemostasis disorders
Publications
History of USPTO decisions and trademark events.
36 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/07/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
09/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/24/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2022
PUBO
PUBLISHED FOR OPPOSITION
03/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/16/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/16/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/30/2021
GNRT
NON-FINAL ACTION E-MAILED
07/30/2021
CNRT
NON-FINAL ACTION WRITTEN
07/30/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/24/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/24/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/16/2021
RFNT
REFUSAL PROCESSED BY IB
02/14/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/26/2021
RFRR
REFUSAL PROCESSED BY MPU
01/25/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/05/2021
CNRT
NON-FINAL ACTION WRITTEN
01/04/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/02/2021
DOCK
ASSIGNED TO EXAMINER
12/29/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens HEMACORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.